Takeshi Soeki
Tokushima University Hospital(JP)
Publications by Year
Research Areas
Cardiovascular Function and Risk Factors, Cardiovascular Disease and Adiposity, Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes, Coronary Interventions and Diagnostics
Most-Cited Works
- → Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance(2016)244 cited
- → C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction(2005)206 cited
- → Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis(2013)204 cited
- → Inflammatory Biomarkers and Atherosclerosis(2016)180 cited
- → Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus(2017)179 cited
- → Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice(2015)171 cited
- → Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction(2007)143 cited
- → STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases(2021)134 cited
- → Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice(2020)119 cited
- → Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse(2016)115 cited